Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
for
Heart Failure, Diabetes
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 0+
Code: NCT06593314
Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Fort Worth TX, Plano TX, Austin TX, Overland Park KS,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
The Role of Sirolimus in Preventing Functional Decline in Older Adults
for
Aging
Location: Dallas TX
Sponsor: Irina Timofte
Sex: All
Age: 65 - 70+
Code: NCT05237687
Phase 2, Recruiting
FORWARD CAD IDE Study
for
Coronary Arterial Disease (CAD)
Location: Dallas TX, Plano TX, Houston TX, Littleton CO,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT06662500
Recruiting
Escitalopram in Asthma Patients With Frequent Exacerbation
for
Asthma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06216535
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Dallas TX, Sherman TX, Kansas City MO, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase 3, Recruiting
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
for
Refractory Angina, Coronary Artery Disease
Location: Plano TX, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: XyloCor Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07048808
Phase 2, Recruiting
Nectero EAST System Clinical Study
for
Abdominal Aortic Aneurysm
Location: Plano TX, Houston TX, Tulsa OK, St Louis MO, Omaha NE,
Sponsor: Nectero Medical, Inc.
Sex: All
Age: 21 - 70+
Code: NCT06001918
Phase 2, Phase 3, Recruiting
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
for
Atrial Fibrillation
Location: Plano TX, Austin TX, Jonesboro AR, Atlanta GA,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07523750
Recruiting
Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
for
Cardiopulmonary
Location: Dallas TX, Plano TX, Rochester MN, Scottsdale AZ,
Sponsor: Prolaio
Sex: All
Age: 18+
Code: NCT05678530
Recruiting
Cardiopulmonary Stress Testing (CPET) AlloSure Study
for
Heart Failure, Transplant; Failure, Heart
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04656080
Recruiting
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
for
Non Small Cell Lung Cancer, Healthy
Location: Dallas TX
Sponsor: OncoHost Ltd.
Sex: All
Age: 18+
Code: NCT05736029
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Dallas TX, Oklahoma City OK, San Antonio TX, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase 3, Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma